UNSPSC 51172201: Pentosan polysulfate sodium

This classification denotes an anticoagulant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 914032762Y. European Medicines Agency schedules Pentosan polysulfate sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14801MIG.

Pentosan polysulfate sodium generally arises in the molecular formula (C5H6NA2O10S2)N. The term PENTOSAN POLYSULFATE SODIUM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, no. 3, 1989, list 29.) As of Q4 2014, PENTOSAN POLYSULFATE SODIUM remains the US FDA Preferred Term for this commodity. Pentosan polysulfate sodium bears US NLM identifiers UMLS ID C0524684 and NCI Concept Code C946. SMILES: C1C(C(C(C(O1)OC2COC(C(C2OS(=O)(=O)O)OS(=O)(=O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)O.

UNSPSC 51172201 Pentosan polysulfate sodium is a Commodity code that maps to pharmaceutical and medical supply procurement, but the recent state and local opportunities tagged under it show minimal direct relevance to the nominal product. The code appears in a diverse set of solicitations spanning offender drug-testing services, water-treatment chemicals, therapeutic pharmacy initiatives, and generic pharmaceutical cooperatives—none of which center on pentosan polysulfate sodium as a procurement target. State and local governments issuing under this code include county supervision departments, county public works agencies, state health and human services commissions, and multistate cooperative purchasing alliances, reflecting the fragmented buying patterns typical of healthcare and chemical supply procurement across multiple jurisdictions and service lines.

The geographic spread includes Texas (Collin County Community Supervision and Corrections Department, Texas HHS Commission), California (Orange County Public Works), and Minnesota (MMCAP), with Minnesota's multistate cooperative suggesting participation beyond its borders. Representative recent opportunities include Collin County's July 2026 RFP for offender specimen collection and drug testing services (due July 23, 2026, estimated value $600,000), Orange County Public Works' IFB for sodium hypochlorite and sulfuric acid (due March 27, 2026), Texas HHS's April 2026 RFI on direct-to-manufacturer prescription programs, and Minnesota MMCAP's January 2026 RFP for generic pharmaceuticals and OTC products (due March 26, 2026). The code shows limited recent activity tied specifically to pentosan polysulfate sodium procurement; the tagged opportunities reflect broader pharmaceutical, chemical, and laboratory supply categories rather than this particular pharmaceutical agent.